Do et al. performed a series of Western blots to assess CYP1A1 and CYP1B1 protein levels in MCF-7, a human breast cancer cell line, following treatment of metformin (1–5 mM) for 24 h. The gene discussed is CYP1A1; the disease is breast carcinoma.